March 10 (Reuters) - LENSAR Inc LNSR.O :
* LENSAR REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.78
* Q4 REVENUE FELL 2.1 PERCENT TO $8.3 MILLION
* LENSAR - REMAIN ON TRACK TO SUBMIT AN APPLICATION FOR
510(K)
CLEARANCE TO U.S. FDA BY END OF Q1 OF 2022, & IF CLEARED,
COMMERCIAL LAUNCH LATER IN 2022
* AS OF DEC 31, 2020, CO HAD CASH, EQUIVALENTS OF $40.6
MILLION
* BELIEVES IT HAS SUFFICIENT CASH TO FUND OPERATIONS THROUGH
FILING OF ITS 510(K) APPLICATION AND EXPECTED LAUNCH OF ALLY IN
2022
* EXPECTS RESEARCH AND DEVELOPMENT EXPENSES TO CONTINUE TO
INCREASE AS IT NEARS THE 510(K) FILING FOR ALLY
Source text for Eikon: ID:nBw9jkZwsa
Further company coverage: LNSR.O
((Reuters.Briefs@thomsonreuters.com;))